News
As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and ...
21m
Stockhead on MSNASX Health Quarterly Wrap: Neurizon turns up the dial on ALS drug progress
Neurizon Therapeutics, Arovella Therapeutics and Singular Health Group are among ASX health companies reporting quarterly ...
Discover how remote clinical trials and apps like Chloe are transforming health research. Learn how you can participate in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results